OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+30.05%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$149M
AUM Growth
+$149M
(+19%)
Cap. Flow
+$6.01M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
99.25%
Holding
19
New
–
Increased
5
Reduced
3
Closed
2
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$7.97M |
| 2 |
Biohaven
BHVN
|
$5.47M |
| 3 |
Ardelyx
ARDX
|
$3.65M |
| 4 |
Palantir
PLTR
|
$75.6K |
| 5 |
Forian
FORA
|
$20.6K |
Top Sells
| 1 |
Phathom Pharmaceuticals
PHAT
|
$4.91M |
| 2 |
Myriad Genetics
MYGN
|
$3.68M |
| 3 |
GeneDx Holdings
WGS
|
$1.71M |
| 4 |
Pacific Biosciences
PACB
|
$820K |
| 5 |
Biodesix
BDSX
|
$51.5K |
Sector Composition
| 1 | Healthcare | 97.14% |
| 2 | Technology | 1.45% |
| 3 | Consumer Discretionary | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GeneDx Holdings
WGS
$3.72B
| $78.7M | 42.83% | 1,023,468 -22,300 | -2% | -$1.71M |
|
|
2
Biohaven
BHVN
$1.63B
| $31.8M | 17.32% | 851,770 +146,520 | +21% | +$5.47M |
|
|
3
Ardelyx
ARDX
$1.53B
| $10.6M | 5.77% | 2,089,431 +720,231 | +53% | +$3.65M |
|
|
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
| $9.2M | 5.01% | 254,773 +220,573 | +645% | +$7.97M |
|
5
QuidelOrtho
QDEL
$1.95B
| $5.27M | 2.87% | 118,291 | – | – |
|
6
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.03M | 2.19% | 535,558 | – | – |
|
|
7
Forian
FORA
$61.3M
| $2.81M | 1.53% | 1,366,107 +10,000 | +0.7% | +$20.6K |
|
|
8
Palantir
PLTR
$372B
| $2.16M | 1.17% | 28,500 +1,000 | +4% | +$75.6K |
|
9
CAVA Group
CAVA
$7.83B
| $2.1M | 1.14% | 18,600 | – | – |
|
|
10
Phathom Pharmaceuticals
PHAT
$864M
| $1.18M | 0.64% | 145,064 -604,423 | -81% | -$4.91M |
|
|
11
Pacific Biosciences
PACB
$393M
| $512K | 0.28% | 279,638 -448,239 | -62% | -$820K |
|
12
Biogen
BIIB
$19.4B
| $369K | 0.2% | 2,412 | – | – |
|
13
EyePoint Pharmaceuticals
EYPT
$797M
| $242K | 0.13% | 32,500 | – | – |
|
|
14
Biodesix
BDSX
$62.6M
| – | – | -28,916 | Closed | -$51.5K |
|
|
15
Myriad Genetics
MYGN
$593M
| – | – | -134,500 | Closed | -$3.68M |
|
16
Novavax
NVAX
$1.21B
| – | – | 0 | – | – |
|
17
Teladoc Health
TDOC
$1.37B
| – | – | 0 | – | – |
|
18
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | 0 | – | – |
|
19
SPDR NYSE Technology ETF
XNTK
$1.25B
| – | – | 0 | – | – |
|